Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$567M |
| 2 |
Kroger
KR
|
+$566M |
| 3 |
AGN
Allergan plc
AGN
|
+$491M |
| 4 |
NXP Semiconductors
NXPI
|
+$366M |
| 5 |
Sherwin-Williams
SHW
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$880M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$731M |
| 3 |
CELG
Celgene Corp
CELG
|
+$395M |
| 4 |
AGN
Allergan Inc
AGN
|
+$320M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Technology | 12.89% |
| 4 | Communication Services | 12.45% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZOES
476
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $13.9M | 0.01% |
418,977
+16,423
| +4% | +$531K |
|
|
MPG
477
DELISTED
Metaldyne Performance Group Inc.
MPG
| $13.9M | 0.01% |
771,588
+59,364
| +8% | +$1.1M |
|
478
Q2 Holdings
QTWO
$3.89B
| $13.8M | 0.01% |
652,262
+189,977
| +41% | +$3.75M |
|
|
ACOR
479
DELISTED
Acorda Therapeutics
ACOR
| $13.2M | 0.01% |
3,312
+7
| +0.2% | +$32.1K |
|
|
SUM
480
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $13.1M | 0.01% |
+628,021
| New | +$12.8M |
|
481
Douglas Emmett
DEI
$1.99B
| $13.1M | 0.01% |
438,838
-8,962
| -2% | -$261K |
|
|
FEIC
482
DELISTED
FEI COMPANY
FEIC
| $13.1M | 0.01% |
171,307
-3,004
| -2% | -$240K |
|
483
Century Aluminum
CENX
$4.47B
| $12.9M | 0.01% |
+932,585
| New | +$18.8M |
|
|
AVDL
484
DELISTED
Avadel Pharmaceuticals
AVDL
| $12.8M | 0.01% |
713,770
+2,263
| +0.3% | +$35.4K |
|
485
Madrigal Pharmaceuticals
MDGL
$11.1B
| $12.7M | 0.01% |
186,776
+85,924
| +85% | +$7.37M |
|
486
Qualys
QLYS
$5.45B
| $12.5M | 0.01% |
268,992
+16,900
| +7% | +$723K |
|
487
PUT
Incyte
INCY
$24B
| $11.9M | 0.01% |
+130,000
| New | +$10.7M |
|
|
FCSC
488
DELISTED
Fibrocell Science Inc.
FCSC
| $11.9M | 0.01% |
175,848
-2,798
| -2% | -$180K |
|
489
Xencor
XNCR
$1.44B
| $11.5M | 0.01% |
+750,508
| New | +$11.8M |
|
490
CDW
CDW
$18.9B
| $11M | 0.01% |
+294,668
| New | +$10.7M |
|
|
RLYP
491
DELISTED
RELYPSA INC COM
RLYP
| $10.8M | 0.01% |
+300,202
| New | +$10.8M |
|
|
WBC
492
DELISTED
WABCO HOLDINGS INC.
WBC
| $10.5M | 0.01% |
85,687
-17,848
| -17% | -$1.94M |
|
|
FOMX
493
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $10.1M | 0.01% |
1,088,495
+480,847
| +79% | +$4.3M |
|
|
LMOS
494
DELISTED
Lumos Networks Corp
LMOS
| $10.1M | 0.01% |
658,660
-12,942
| -2% | -$218K |
|
|
NXTM
495
DELISTED
NxStage Medical Inc.
NXTM
| $9.98M | 0.01% |
+576,672
| New | +$10.2M |
|
|
DSCI
496
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $9.63M | 0.01% |
1,136,928
+262
| +0% | +$2.23K |
|
497
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $9.2M | 0.01% |
44,585
+41,903
| +1,562% | +$8.65M |
|
498
BioCryst Pharmaceuticals
BCRX
$2.24B
| $8.79M | 0.01% |
+973,099
| New | +$10.1M |
|
|
ACGN
499
DELISTED
Aceragen Inc
ACGN
| $7.95M | 0.01% |
+15,762
| New | +$9.61M |
|
|
GNMX
500
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $7.8M | 0.01% |
968,792
-12,400
| -1% | -$93.5K |
|
Similar funds
Jennison Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Jennison Associates held 801 positions worth $109B, up 2.1% from $107B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q1 2015 filing shows 86 new, 297 increased, 319 reduced and 92 closed positions. Its largest new stake was NXP Semiconductors: 4,151,977 shares worth $417M. The largest sale was PRECISION CASTPARTS CORP, an estimated $880M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q1 2015 buy was NXP Semiconductors: 4,151,977 shares worth $417M.
- Jennison Associates added most to Time Warner Inc in Q1 2015, an estimated $567M increase.
- Jennison Associates's biggest Q1 2015 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $731M.
- Jennison Associates fully exited PRECISION CASTPARTS CORP in Q1 2015, selling an estimated $880M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q1 2015.
- Jennison Associates opened 86 new positions and closed 92 in Q1 2015.
- Jennison Associates's portfolio value rose 2.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.